Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

salicylic acid

NULL

salicylic acid (NULL) is an FDA-listed pharmaceutical active ingredient.

TGA: approved
Patents linked 6
Pipeline programs 21
News articles 1
Drug details — salicylic acid
Class
—
Route
—
Patents
6
Programs
21
Data quality
0.78
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

salicylic acid (NULL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN salicylic acid
Brand NULL

Approval history

Authority Status Date
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Browse pipeline
  1. 20-01/BetaSal-S Phase 3 · Alphapharm · Chronic stable plaque psoriasis
  2. APHP240889 Phase 3 · PARItec · Aortic bioprothesis implanted patient for valvular heart dis
  3. CAPECITABINE for Locally advanced stage II/III rectal cancer Phase 3 · Telethon Foundation · Locally advanced stage II/III rectal cancer
  4. DSC/08/2357/32 Phase 3 · ITALFARMACO S.P.A · JAK2V617F-positive high-risk Polycythemia Vera
  5. MHICC-2021-001 Phase 3 · George Institute for · Type 2 diabetic patients with no prior cardiovascular (CV) e
  6. R7508-DVT-24120 Phase 3 · Anaxis Pharma · Symptomatic Venous Thromboembolism (VTE)
  7. Wegovy solution for Diabetes Mellitus, Cardiovascul… Phase 3 · Istituto Gentili Italia · Diabetes Mellitus, Cardiovascular disease, Overweight (BMI ≥
  8. -aminosalicylic acid Phase 2 · Ultragenyx UK · Ulcerative Colitis

Related patents

Browse patents

  1. US 10874709

    Conjugate of salicylic acid and peptide

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10449129

    Encapsulates of salicylic acid and polysalicylic acid derivatives

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8828979

    Salicylic acid gel

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7700651

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is salicylic acid?

salicylic acid (NULL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for salicylic acid?

NULL is a marketed brand name for salicylic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.